Groupe Français D'étude Des Maladies Inflammatoires De Loeil
Clinical trials sponsored by Groupe Français D'étude Des Maladies Inflammatoires De Loeil, explained in plain language.
-
Rare artery disease linked to higher heart attack and stroke risk
Knowledge-focused CompletedThis study uses French national health data to compare the risk of major heart problems—like heart attack, stroke, and death—in people with Takayasu arteritis versus similar people without the disease. It also looks at how steroid use may affect these risks. The goal is to better…
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Which drug protects the heart better in giant cell arteritis?
Knowledge-focused CompletedThis study looked at over 1,600 people with giant cell arteritis, a condition that inflames blood vessels and raises heart risks. Researchers compared tocilizumab and methotrexate to see which better prevents heart attacks, strokes, or death. Using French health data, they analyz…
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC